An intently viewed Gilead Sciences Inc test antiviral medication neglected to assist patients with serious COVID-19 of every a clinical preliminary led in China, yet the drugmaker said the discoveries were uncertain in light of the fact that the investigation was ended early. Gilead shares shut down 4.3 percent after the information was unintentionally discharged…